CRISPR Gene Editing Newsletter
Issue #29March 23, 20267 studies

Scientists make CAR T-cell therapy in the body, skipping expensive manufacturing

Gene editing just took a major leap forward this week. Scientists are now creating therapeutic immune cells directly inside patients, engineering heart cells with light, and even making bacteria drug-resistant on purpose (for good reasons). Here's what's happening at the cutting edge of precision medicine.

🎯 CAR T-cells created inside the body bypass costly manufacturing

  • Scientists developed a two-vector system that generates therapeutic CAR T-cells directly inside patients, using CRISPR-Cas9 to integrate CAR genes into T cell-specific locations in the genome

  • The approach achieved therapeutic levels of CAR T-cells in humanized mouse models across multiple cancer types—B cell aplasia, blood cancers, and solid tumors

  • Current CAR T-cell therapy requires extracting patient cells, engineering them in labs over weeks, then reinfusing them—a process costing hundreds of thousands of dollars per patient

Why it matters: This could make CAR T-cell therapy accessible to far more patients by eliminating the lengthy, expensive manufacturing process that currently limits these life-saving treatments to major medical centers.

🏆 Top 0.1% journal 🔗 Nature 🗓️ Mar 19

Key Findings

🔬 Light-activated gene editing reaches heart cells

  • Researchers used photoporation with nanosensitizers to deliver prime editing complexes into human heart muscle cells derived from stem cells

  • The technique achieved prime editing frequencies up to 8.46% in these notoriously hard-to-transfect cardiac cells

  • Unlike viral delivery methods, this approach doesn't integrate foreign DNA into the cell's genome, making it potentially safer for therapeutic applications

💡 This non-viral approach could enable precise heart disease treatments without the safety risks of permanent genetic modifications.

🧪 New lipid nanoparticles target lungs with 90% precision

  • Scientists tested 444 different lung-targeting lipids and found that 'tripod-like' structures with quaternary amine heads and three long alkyl chains worked best

  • The top performer (1A7B13) showed 25.5-fold better mRNA delivery and 9.2-fold better gene editing compared to current benchmark systems

  • These nanoparticles achieved over 90% selectivity for lung tissue, successfully delivering therapeutic IL-10 mRNA in a lung injury model

💡 Highly selective lung delivery could transform treatments for respiratory diseases, fibrosis, and lung cancer.
🥇 Top 1% journal 🔗 Nature biomedical engineering 🗓️ Mar 18

🎯 Self-destructing gene editor treats Huntington's disease

  • A self-inactivating CRISPR system eliminated 60-90% of toxic Huntington protein and 90% of protein clumps in mouse brains

  • The treatment rescued motor problems, weight loss, and extended lifespan even when given after symptoms appeared

  • The system shuts itself off after editing to prevent long-term off-target effects, addressing a major safety concern with permanent gene editors

💡 This 'one-and-done' approach could provide lasting benefits for neurodegenerative diseases while minimizing long-term risks.
🥈 Top 2% journal 🔗 Science advances 🗓️ Mar 18

🦠 Making bacteria drug-resistant actually fights superbugs

  • Scientists used CRISPR to eliminate carbapenemase genes from drug-resistant Klebsiella pneumoniae, reducing antibiotic resistance by more than 64-fold

  • In one strain, the treatment completely removed three different resistance plasmids simultaneously

  • The approach also eliminated quinolone resistance genes alongside the main targets due to their location on the same genetic elements

💡 Deliberately targeting resistance genes with CRISPR could help restore the effectiveness of existing antibiotics against superbugs.
Top 20% journal 🔗 Biomedical journal 🗓️ Mar 18

🔍 Gut viruses carry 651 anti-CRISPR weapons

  • Researchers identified 651 phage-encoded proteins that can disable bacterial CRISPR immune systems in the human gut

  • 36 of these proteins were confirmed to block CRISPR-Cas activity in laboratory tests

  • 213 proteins called GutAcr were found in 26% of microbial species and can both regulate their own production and inhibit CRISPR systems

💡 Understanding how gut viruses evade bacterial defenses could lead to new biotechnology tools and insights into microbiome dynamics.
🥇 Top 1% journal 🔗 Cell host & microbe 🗓️ Mar 19

📊 Compact gene editors work better in bacteria

  • Scientists engineered smaller OMEGA-based prime and base editing systems that outperform existing tools in E. coli

  • These compact editors show superior efficiency and versatility while being easier to deliver due to their reduced size

  • The systems work well with high-throughput screening platforms and can enhance protein production and metabolic engineering

💡 Smaller, more efficient gene editors could accelerate biotechnology applications from drug discovery to biofuel production.
🥉 Top 5% journal 🔗 Trends in biotechnology 🗓️ Mar 18

Implications

This week's research shows gene editing moving from laboratory curiosity to practical medicine—with treatments being delivered directly in patients, safer self-limiting systems, and highly targeted approaches for specific organs. The field is rapidly solving the delivery and safety challenges that have limited clinical applications.

Studies in this issue

Primary sources used for this newsletter.

  1. Reprogramming T cells directly inside the body at specific sites
    main storyNature2026-03-19PMID 41851456
  2. Human gut viruses produce proteins that help them avoid type II CRISPR immune defense in different ways
    key findingCell host & microbe2026-03-19PMID 41856106
  3. Light-based delivery of gene-editing tools into human stem cell–derived heart cells for heart gene correction
    key findingBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026-03-20PMID 41861527
  4. Using CRISPR to remove antibiotic resistance genes and restore drug sensitivity in Klebsiella pneumoniae bacteria
    key findingBiomedical journal2026-03-18PMID 41850654
  5. Using a self-turning-off gene editing tool at different ages helps improve Huntington's disease symptoms over time in mice
    key findingScience advances2026-03-18PMID 41849610
  6. 'Tripod-shaped' lung-targeting fats for highly efficient and selective gene delivery and editing particles
    key findingNature biomedical engineering2026-03-18PMID 41845088
  7. Omega-based prime and base gene editing tools in E. coli bacteria
    key findingTrends in biotechnology2026-03-18PMID 41846215

Continue reading

All CRISPR Gene Editing issues